Prudential Financial Inc Cumberland Pharmaceuticals Inc Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.92 - $2.75 $8,832 - $12,650	-4,600 Reduced 30.87%	10,300 $20,000
Q4 2022 Feb 14, 2023	BUY	$2.11 - $2.6 $9,706 - $11,960	4,600 Added 44.66%	14,900 $0
Q2 2022 Aug 15, 2022	SELL	$1.93 - $3.03 $37,635 - $59,084	-19,500 Reduced 65.44%	10,300 $21,000
Q3 2018 Nov 07, 2018	BUY	$5.5 - $6.3 $550 - $630	100 Added 0.34%	29,800 $0
Q2 2018 Aug 13, 2018	BUY	$5.91 - $6.9 $53,781 - $62,790	9,100 Added 44.17%	29,700 $0
Q1 2018 May 04, 2018	BUY	$6.62 - $7.12 $136,372 - $146,672	20,600 New	20,600 $0

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.